This content is from: Patents

Bayer: urgent need for patent term extension in China

Jörg Thomaier, head of IP at Bayer, explains why PTE will help the pharma industry and what an ideal patent linkage system looks like

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial

Related